Tag: Roadmaps to Nature Positive

WBCSD and pharmaceutical companies release first sector Roadmap towards nature-positive action

The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and supported by PwC UK, has published the Roadmap to Nature Positive: Foundations for the Pharmaceutical Sector (‘Roadmap’). This publication marks a critical milestone in the pharmaceutical sector’s efforts to understand its nature-related impacts and dependencies and identify key actions to […]

Roadmaps to Nature Positive: Foundations for the pharmaceutical sector

The healthcare sector, while focused on improving human health, is a contributor to environmental impacts. For example, the sector is responsible for around 5% of global greenhouse gas (GHG) emissions, accentuating the industry’s impact on the natural environment. While the continuing advancement of medical technology has contributed to the extension of global life expectancy from […]

Exploring nature-positive buildings

The built environment sector is critical to achieving a nature-positive future, as it is responsible for nearly 30% of biodiversity loss globally, 50% of global raw materials extraction, 40% of waste streams, and 40% of CO2 emissions. By 2025, the construction industry is predicted to generate 2.2 billion tons of waste annually. Of this, approximately […]

Pharma companies mark a key milestone on their journey to nature positive

World Business Council for Sustainable Development (WBCSD) is collaborating with leading companies in the sector, with support from PwC UK, to develop a Roadmap to Nature Positive for the pharmaceutical (pharma) sector. Today marks a key milestone in the Roadmap’s development with the release of the draft ‘Overview for the Pharmaceutical Sector: Priority actions towards […]

Corporate case studies: Leveraging the Roadmap to Nature Positive

Our member case studies help to bridge the gap between theory and practice. These examples show how companies within the agri-food system are navigating the nature-positive journey, offering valuable insights into the particular opportunities and challenges that businesses encounter along the way. As each organization confronts a combination of unique and shared hurdles, it is important […]

WBCSD partners with leading pharmaceutical companies to develop a new ‘Roadmap to Nature Positive’

WBCSD in partnership with GSK is convening the pharma sector including AstraZeneca, Bayer, Novartis, Novo Nordisk, Roche and Takeda, to develop an additional tool to the Roadmaps to Nature Positive series, focusing on the pharmaceutical sector. All businesses depend on and impact nature through their direct operations and/or value chains. To accelerate business contribution toward […]